Pharma Mar | PHM - Umsatzkosten





Umsatzkosten Veränderung Datum
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Almirall EUR 191.5M 2.29M 2025-12
Avita Medical AUD 3.3M 166K 2025-12
Ionis Pharmaceuticals USD 3M 5M 2026-03
IQVIA Holdings USD 3.08B 161M 2026-03
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Moderna USD 955M 503M 2026-03
Organon & Co USD 766M 21M 2025-12
Pharma Mar EUR 3.66M 116K 2026-03
Revvity USD 323.46M 26.93M 2026-03
Viatris USD 2.36B 195.9M 2026-03
Xeris Pharmaceuticals USD 13.66M 49K 2025-12